(Q33459798)

English

Phase II studies of mitoxantrone in patients with primary liver cancer

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

27 July 2017

Phase II studies of mitoxantrone in patients with primary liver cancer (English)

1 reference

stated in

Europe PubMed Central

27 July 2017

1 reference

Falkson G

1

1 reference

stated in

Europe PubMed Central

PubMed ID

4019121

retrieved

27 July 2017

Coetzer BJ

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

4019121

retrieved

27 July 2017

language of work or name

1 reference

1 January 1985

1 reference

stated in

Europe PubMed Central

27 July 2017

Investigational New Drugs

1 reference

stated in

Europe PubMed Central

27 July 2017

3

1 reference

stated in

Europe PubMed Central

27 July 2017

2

1 reference

stated in

Europe PubMed Central

27 July 2017

187-189

1 reference

stated in

Europe PubMed Central

27 July 2017

https://scigraph.springernature.com/pub.10.1007/bf00174168

0 references

cites work

A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/4019121

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/4019121

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/4019121

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00174168

1 reference

stated in

Europe PubMed Central

PubMed ID

4019121

retrieved

27 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

PubMed ID

4019121

retrieved

27 July 2017

(Q33459798)

Phase II studies of mitoxantrone in patients with primary liver cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)